{"id":"tp-42939","type":"article-newspaper","title":"Palvella Announces FDA Priority Review for Qtorin Rapamycin Application","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/42939","datePublished":"2026-10-28T20:48:38.000Z","dateModified":"2026-10-28T20:48:38.000Z","language":"en","abstract":"The application seeks U.S. approval for the topical candidate, and Palvella shares traded higher Wednesday.","section":"Regulation","references":[]}